Comparison

BPC-157TB-500

The two leading regenerative peptides in the category — BPC-157 is a protective fragment from gastric juice (15 AA), TB-500 is the active fragment of Thymosin Beta-4 (G-actin binding). The literature often combines them.

Spec	A BPC-157	B TB-500
Origin	Gastric juice protective protein (Sikiric, Zagreb)	Fragment 17-23 of Thymosin β-4 (Goldstein, GWU 1981)
Length	15 amino acids	7 amino acids (LKKTETQ)
Primary mechanism	Angiogenesis via VEGFR2 + NO signaling	G-actin binding → cell migration
Half-life	~6 hours	2-3 days
Dosing	Daily s.c.	2× weekly s.c.
Gastric stability	Yes — oral administration viable	No
Studied for	Tendons, GI tract, nerve tissue, joints	Skeletal and cardiac muscle, skin, cornea

Choose A when

BPC-157

GI tract regeneration, tendons (Achilles model), nerve tissue, joints. Oral option is a plus.

See full profile

Choose B when

TB-500

Systemic skeletal and cardiac muscle recovery, skin. More convenient at 2× weekly dosing.

See full profile

Verdict

Different mechanisms, not competitors. Standard recovery protocols combine them — BPC drives vasculature, TB-500 moves cells into it.

Frequently asked

What people ask

Can BPC-157 and TB-500 be stacked?

Yes — this is the classic recovery duo. The two work through different but complementary mechanisms (angiogenesis + cell migration). Frequently sold as a 5+5 or 10+10 mg blend.

Other comparisons

Keep exploring

Semaglutide vs Tirzepatide

Semaglutide vs Retatrutide

Tirzepatide vs Retatrutide

Ipamorelin vs CJC-1295

Last reviewed: 6 May 2026by PeptidLabs Editorial

Comparison

BPC-157TB-500

Spec	A BPC-157	B TB-500
Origin	Gastric juice protective protein (Sikiric, Zagreb)	Fragment 17-23 of Thymosin β-4 (Goldstein, GWU 1981)
Length	15 amino acids	7 amino acids (LKKTETQ)
Primary mechanism	Angiogenesis via VEGFR2 + NO signaling	G-actin binding → cell migration
Half-life	~6 hours	2-3 days
Dosing	Daily s.c.	2× weekly s.c.
Gastric stability	Yes — oral administration viable	No
Studied for	Tendons, GI tract, nerve tissue, joints	Skeletal and cardiac muscle, skin, cornea

Choose A when

BPC-157

GI tract regeneration, tendons (Achilles model), nerve tissue, joints. Oral option is a plus.

See full profile

Choose B when

TB-500

Systemic skeletal and cardiac muscle recovery, skin. More convenient at 2× weekly dosing.

See full profile

Verdict

Different mechanisms, not competitors. Standard recovery protocols combine them — BPC drives vasculature, TB-500 moves cells into it.

Frequently asked

What people ask

Can BPC-157 and TB-500 be stacked?

Yes — this is the classic recovery duo. The two work through different but complementary mechanisms (angiogenesis + cell migration). Frequently sold as a 5+5 or 10+10 mg blend.

Other comparisons

Keep exploring

Semaglutide vs Tirzepatide

Semaglutide vs Retatrutide

Tirzepatide vs Retatrutide

Ipamorelin vs CJC-1295

Last reviewed: 6 May 2026by PeptidLabs Editorial